Editor’s Desk: A burning issue deserves better answer – and soon
By
James M. Berklan
Jan 13, 2006
There is a scene in the George C. Scott movie “Patton,” where the title character is trying to impress upon foreign colleagues that enemy forces are a little too close for safety’s sake....
Researchers find Parkinson’s disease gene
By
Haymarket Media
Oct 26, 2004
The discovery of a defective gene responsible for Parkinson’s disease could mean better research for preventing or delaying the disease, according to experts.
Lesinki promoted to VP of marketing
Feb 14, 2017
Jennifer Lesinki has been promoted to vice president of marketing at St. John’s in Rochester, NY.
Bristol-Myers Squibb discontinues its antidepressant Serzone
By
Haymarket Media
May 26, 2004
Bristol-Myers Squibb has discontinued the manufacture and sales of its antidepressant Serzone, which has been linked to 55 cases of liver disease, including 20 deaths. The official halt date will be June...
Cost of meds for elderly up 6.3% over last year, AARP survey says
By
Haymarket Media
Sep 21, 2006
Manufacturer prices for the most commonly prescribed drugs to people 50 and older increased by an average of 6.3% during the 12-month period ending in June, according to a recently released AARP survey....
Omnicare shows second quarter profit
By
McKnight's Staff
Aug 01, 2012
Omnicare Inc. turned a profit in the second quarter, according to a statement from the nursing home pharmacy giant. Omnicare earned $18.7 million, or 17 cents per share, for the three months ended June...
Alzheimer’s gene linked to post-surgery delirium
By
Haymarket Media
Aug 28, 2007
Elderly people who have a gene associated with increased risk of late-onset Alzheimer’s disease and other types of dementia also might be predisposed to delirium after major surgery, new research...
Popular diabetes drug could be dangerous, study finds
By
Haymarket Media
May 23, 2007
A widely prescribed drug to treat type 2 diabetes increases users’ risk for heart attack, according to study findings released this week.
Common constipation drug pulled from the market
By
Haymarket Media
Apr 05, 2007
The U.S. Food and Drug Administration has pulled Zelnorm from the market because it can cause an increased risk of heart attack, angina, stroke and death.
Pharmaceutical company to pay $1 million to settle claims on switching drugs
By
Haymarket Media
Aug 30, 2004
The Maine subsidiary of Omnicare Pharmacy, a Fortune 500 company, agreed to pay $1 million to settle claims that it switched nursing home patients’ prescriptions to a medication that would be more...